NCT05292859 — Alaunos Therapeutics cancer immunotherapy trial
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Registry record
| Registry ID | NCT05292859 ↗ |
|---|---|
| Lead sponsor | Alaunos Therapeutics |
| Collaborators | — |
| Phase | — |
| Status | Completed |
| Indication | Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer, Non-small Cell Lung Cancer, Cholangiocarcinoma, Ovarian Cancer, Ovary Neoplasm, Squamous Cell Lung Cancer, Adenocarcinoma of Lung, Adenosquamous Cell Lung Cancer |
| Enrollment | 8 participants |
| Start date | 2022-10-07 |
| Primary completion | 2025-04-20 |
| Last registry update | 15 Oct 2026 |
Every field above is mirrored from the study record on ClinicalTrials.gov (NCT05292859), which the sponsor maintains and which carries the full protocol summary, eligibility criteria, sites and contacts. No neoantigen vaccine is approved anywhere yet — every program here is investigational, and inclusion is not an endorsement. See the methodology for how the tracker is built.
Where this fits
Daily coverage of the modality, tumor type and players this study touches:
Related trials
FAQ
What phase is NCT05292859?
NCT05292859 (Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs) is registered on ClinicalTrials.gov as having no assigned phase, sponsored by Alaunos Therapeutics.
Is NCT05292859 recruiting?
As of the 2026-10-15 registry update, NCT05292859 is listed as "Completed". Eligibility criteria, study sites and contacts are maintained by the sponsor on the ClinicalTrials.gov record.
Who is running NCT05292859?
The lead sponsor is Alaunos Therapeutics.
What condition does NCT05292859 study?
The registered conditions are Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer, Non-small Cell Lung Cancer, Cholangiocarcinoma, Ovarian Cancer, Ovary Neoplasm, Squamous Cell Lung Cancer, Adenocarcinoma of Lung, Adenosquamous Cell Lung Cancer. Primary completion is listed as 2025-04-20.
Are results available for NCT05292859?
neoag.ai mirrors the registry's factual fields — sponsor, phase, status and dates — and does not publish trial results. Any posted results, publications, or outcome measures appear on the ClinicalTrials.gov record for NCT05292859.
Back to the full neoantigen vaccine trial tracker — 106 studies, refreshed daily from ClinicalTrials.gov. Background: primer, glossary, and the companies landscape.